Telix Pharmaceuticals (TLX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TLX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Bell Potter says this growing ASX 200 stock can rise over 40%July 12, 2025 | msn.comTelix Pharmaceuticals (TLX) Announces That Gozellix® is Commercially AvailableJuly 10, 2025 | msn.comTelix Pharmaceuticals Limited (TLX) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.com11 Best Mid-cap Healthcare Stocks to Buy According to Hedge FundsJuly 9, 2025 | insidermonkey.comTelix Pharmaceuticals Ltd Ordinary Shares TLX - MorningstarJune 26, 2025 | morningstar.comMTelix shares push higher on investor day updateJune 11, 2025 | msn.comTelix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.June 11, 2025 | finance.yahoo.comTelix Pharmaceuticals (ASX:TLX) Gains Portugal Approval for Illuccix in Prostate Cancer DetectionJune 4, 2025 | finance.yahoo.comTelix Manufacturing Solutions (TMS) Established in Yokohama, JapanJune 4, 2025 | finance.yahoo.comTelix to Host Investor Day in New York City on June 11, 2025May 23, 2025 | morningstar.comMTelix at ANZSNM Annual Scientific Meeting 2025May 20, 2025 | finance.yahoo.comA Note On Telix Pharmaceuticals Limited's (ASX:TLX) ROE and Debt To EquityMay 16, 2025 | finance.yahoo.comTelix Pharmaceuticals Limited: Telix's Illuccix PSMA-PET Imaging Agent Approved in the Czech RepublicMay 5, 2025 | finanznachrichten.deTelix Pharmaceuticals Limited: Telix's Illuccix PSMA-PET Imaging Agent Approved in FranceApril 29, 2025 | finanznachrichten.deTelix setback in drug approval in US, amid Trump workforce cuts to FDAApril 28, 2025 | afr.comTelix Pharmaceuticals Ltd ADR (TLX)April 27, 2025 | investing.comTelix: A masterclass in what this game is all aboutApril 24, 2025 | msn.comHealth Check: Telix shares rocket after bullish quarterly sales updateApril 23, 2025 | msn.comThe ASX's hottest company has gone from zero revenue to $1.2 billion in 4 yearsApril 23, 2025 | msn.comTelix shares rocket 15% on stellar Q1 sales updateApril 23, 2025 | msn.comTelix Pharmaceuticals Limited: IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy CandidateApril 15, 2025 | finanznachrichten.deTelix Pharmaceuticals Limited: Illuccix Prostate Cancer PSMA-PET Imaging Agent Approved in SwedenApril 15, 2025 | finanznachrichten.deTelix Pharmaceuticals Limited: Telix Appoints Paul Schaffer as Chief Technology OfficerApril 7, 2025 | finanznachrichten.deTelix begins trial for new soft tissue sarcoma therapyApril 3, 2025 | investing.comARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®April 1, 2025 | markets.businessinsider.comHealth Check: Opthea’s solvency in question after monumental phase III eye disease trial failureMarch 23, 2025 | msn.comTelix Pharmaceuticals Ltd Share Price (TLX.US)March 21, 2025 | lse.co.ukUp 113% in a year, guess which ASX 200 healthcare stock just scored another FDA winMarch 20, 2025 | msn.comFDA Approves New Prostate Cancer Imaging Agent Gozellix®March 20, 2025 | finance.yahoo.comTelix shares slip 11% from highs. Time to buy this high flying biotech?March 20, 2025 | msn.comIlluccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin AmericaMarch 18, 2025 | markets.businessinsider.comUp 136% in a year, why is this ASX 200 share slipping on Wednesday?March 11, 2025 | msn.comHealth Check: Telix ‘mini me’ Clarity moves to next phase of prostate cancer therapy trialMarch 4, 2025 | msn.comGuess which ASX 200 company co-founders just sold $118 million in sharesFebruary 27, 2025 | msn.comFDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority ReviewFebruary 26, 2025 | markets.businessinsider.comHEALTH CHECK: After an ‘extraordinary’ year, analysts reckon Telix has a lot more tiger in the tankFebruary 23, 2025 | msn.comTelix share price jumps 13% on FY24 profit surgeFebruary 20, 2025 | msn.comStar biotech Telix makes $1.2b revenue pledgeFebruary 20, 2025 | afr.comUp 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'February 12, 2025 | msn.comTelix Pharmaceuticals Limited: Illuccix Approved in the United KingdomFebruary 12, 2025 | finanznachrichten.de10 Best Long Term ASX Stocks to Buy NowFebruary 11, 2025 | insidermonkey.comTelix Pharmaceuticals Limited: Illuccix Approved in DenmarkFebruary 11, 2025 | finanznachrichten.deWhy Dropsuite, Monadelphous, Sigma, and Telix shares are storming higher todayJanuary 27, 2025 | fool.com.auTelix Pharmaceuticals Limited (TLX)January 25, 2025 | finance.yahoo.comImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discoveryJanuary 22, 2025 | uk.finance.yahoo.comTelix Pharmaceuticals Limited: Illuccix Receives European ApprovalJanuary 16, 2025 | finanznachrichten.deGuess which ASX 200 stock is jumping to record high on big European newsJanuary 16, 2025 | msn.comGuess which ASX 200 share is up 7% after smashing FY24 guidanceJanuary 13, 2025 | msn.comTelix Pharmaceuticals Limited: Scintimun Commercialization Partnership with Curium PharmaJanuary 13, 2025 | finanznachrichten.deUp 120% in a year, ASX 200 healthcare stock dips on US acquisitionJanuary 12, 2025 | msn.com Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address TLX Media Mentions By Week TLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLX News Sentiment▼0.000.46▲Average Medical News Sentiment TLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLX Articles This Week▼02▲TLX Articles Average Week Get Telix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Oxford Nanopore Technologies News Genus News Biotest Aktiengesellschaft News PureTech Health News Oxford Biomedica News Faron Pharmaceuticals Oy News Fennec Pharmaceuticals News Cybin News Avacta Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:TLX) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLX Stock Alerts